Real life Effectiveness and safety of an induction treatment with tofacitinib in patients with Ulcerative Colitis: First results of the French TOFAST cohort

被引：0
|
作者：
Fumery, M. [1 ]
Bouhnik, Y. [2 ]
Faure, P. [3 ]
Bouzidi, A. [4 ]
Brault, Y. [4 ]
Peyrin-Biroulet, L. [5 ]
Laharie, D. [6 ]
机构：
[1] CHU Amiens, Gastroenterol & Hepatol, Amiens, France
[2] Groupe Hosp Ambroise Pare Hartmann, Inst MICI, Neuilly sur Seine, France
[3] Clin Pasteur Hepatol & Gastro Enterol, Tououse, France
[4] Pfizer Infammat & Immunol, Paris, France
[5] Univ Hosp, Gastroenterol, Nancy, France
[6] CHU Bordeaux, Hepatol & Gastroenterol, Bordeaux, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P450
引用
收藏
页码：580 / 581
页数：2
相关论文
共 50 条
  • [31] Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
    Bossa, Fabrizio
    Biscaglia, Giuseppe
    Valvano, Maria Rosa
    Costantino, Giuseppe
    Lauria, Angelo
    Clemente, Rocco
    Ferracane, Concetta
    Shahini, Endrit
    Mendolaro, Marco
    Grossi, Laurino
    Mazzuoli, Silvia
    Rispo, Antonio
    Pranzo, Giuseppe
    Sebkova, Ladislava
    Tursi, Antonio
    Miranda, Agnese
    Patturelli, Marta
    Spagnuolo, Rocco
    Ricciardelli, Cristina
    Sgarro, Caterina
    Paese, Pietro
    Inserra, Gaetano
    Azzarone, Alessandro
    Nardone, Olga
    Fries, Walter
    Buccianti, Nello
    Privitera, Antonino Carlo
    Principi, Maria Beatrice
    Cappello, Maria
    Guglielmi, Francesco William
    Romano, Marco
    Riegler, Gabriele
    Fanigliulo, Libera
    Melina, Raffaele
    Andriulli, Angelo
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (06) : 1767 - 1776
  • [32] EFFECTIVENESS AND SAFETY OF ADALIMUMAB AS FIRST LINE BIOLOGICAL TREATMENT IN ULCERATIVE COLITIS
    Lopez-Cardona, Julia
    Sharma, Esha
    Lal, Natasha
    Dart, Robin
    Anderson, Simon
    Mawdsley, Joel
    Ray, Shuvra
    Samaan, Mark
    Irving, Peter
    GUT, 2023, 72 (SUPPL_2) : A77 - A78
  • [33] Effectiveness and safety of adalimumab as first line biological treatment in Ulcerative Colitis
    Lopez Cardona, J.
    Sharma, E.
    Lal, N.
    Anderson, S.
    Dart, R.
    Mawdsley, J.
    Ray, S.
    Samaan, M.
    Irving, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1596 - I1597
  • [34] Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study
    Straatmijer, T.
    Visschedijk, M.
    de Vries, A.
    Hoentjen, F.
    van Bodegraven, A. A.
    Bodelier, A. G. L.
    de Boer, N. K. H.
    Dijkstra, G.
    Festen, E. A. M.
    Horjus, C.
    Jansen, J. M.
    Jharap, B.
    Mares, W.
    Oldenburg, B.
    Ponsioen, C. Y.
    Romkens, T. E. H.
    Srivastava, N.
    van der Voorn, M. M.
    West, R. L.
    van der Woude, J. C.
    Wolvers, M. D. J.
    Pierik, M.
    van der Meulen, A. E.
    Duijvestein, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I119 - I120
  • [35] TREATMENT PERSISTENCE RATES WITH TOFACITINIB IN A REAL-WORLD COHORT OF ANTI-TNF REFRACTORY ULCERATIVE COLITIS PATIENTS
    Conley, Thomas
    Colclough, James
    Liu, Eleanor
    Razanskaite, Violeta
    Jakobek, William
    Limdi, Jimmy
    Flanagan, Paul
    Subramanian, Sreedhar
    GUT, 2021, 70 : A88 - A89
  • [36] Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis
    Gros, Beatriz
    Goodall, Mairi
    Plevris, Nik
    Constantine-Cooke, Nathan
    Elford, Alexander T.
    O'Hare, Claire
    Noble, Colin
    Jones, Gareth-Rhys
    Arnott, Ian D.
    Lees, Charlie W.
    JOURNAL OF CROHNS & COLITIS, 2023,
  • [37] Real-life effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: An Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter cohort study
    Baek, J. E.
    Kim, E. S.
    Kim, K. O.
    Jo, H. H.
    Hwang, S. W.
    Park, S. H.
    Jang, B. I.
    Kim, E. Y.
    Yang, S. K.
    Kim, S. K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I780 - I781
  • [38] Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
    D'Amico, Ferdinando
    Parigi, Tommaso Lorenzo
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [39] Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
    Yoon, Hyuk
    Ye, Byong Duk
    Kang, Sang-Bum
    Lee, Kang-Moon
    Choi, Chang Hwan
    Jo, Joo-young
    Woo, Juwon
    Cheon, Jae Hee
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [40] Frequency and causes of prolongation of the induction course of tofacitinib in patients with ulcerative colitis in conditions of real clinical practice
    Knyazev, O.
    Kagramanova, A.
    Lishchinskaya, A.
    Parfenov, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S494 - S494
12345